van de Wal H J, Lacquet L K, Jongerius C M
Thorac Cardiovasc Surg. 1984 Jun;32(3):170-3. doi: 10.1055/s-2007-1023376.
The incidence rate of chest wall invasion in bronchogenic carcinoma is difficult to estimate, but is possibly as high as 5%. These cancers can be locally extensive without systemic dissemination. From 1973 to 1982, 9 patients in our hospital underwent en bloc pulmonary and partial chest wall resection for bronchogenic carcinoma with local invasion of the thoracic wall. All the patients were male, their ages ranging from 49 to 67 years. Pain was the most prominent symptom. Bronchoscopy examination revealed no tumors in 7 of the 9 patients, in one a tumor was seen in the apex of the right lower lobe and in another in the apex of the right upper lobe. Seven lobectomies and 2 pneumonectomies were performed. The macroscopic size of the tumour ranged from 3 to 17 cm, the number of partially resected ribs ranged from 1 to 4. In 8 cases squamous cell carcinoma was found, in one adenocarcinoma. After operation 7 patients were classified as T3N0M0 and 2 as T3N1M0. One T3N0M0 patient died shortly after operation due to a lung embolism. Two out of the 6 patients with T3N0M0 neoplasm survived more than 5 years, none of the patients with T3N1M0 neoplasm survived more than 3 months. Late deaths were due to recurrent carcinoma in the chest wall (2 cases), cerebral metastasis (1 case), cardiac failure (1 case) and unknown causes (2 cases). In cases where the lymph nodes are not involved, the survival rate is not unfavorably influenced by chest wall invasion. In the literature the mean operative mortality rate is 12%, the median survival time approximately one year and the mean 5-year survival rate 18%; resection is also of great importance in relieving pain.
支气管源性癌侵犯胸壁的发生率难以估计,但可能高达5%。这些癌症可局部广泛侵犯而无全身播散。1973年至1982年,我院9例支气管源性癌侵犯胸壁的患者接受了肺及部分胸壁整块切除术。所有患者均为男性,年龄在49至67岁之间。疼痛是最突出的症状。9例患者中7例支气管镜检查未发现肿瘤,1例在右下叶尖段发现肿瘤,另1例在右上叶尖段发现肿瘤。施行7例肺叶切除术和2例全肺切除术。肿瘤肉眼大小为3至17cm,部分切除的肋骨数量为1至4根。8例为鳞状细胞癌,1例为腺癌。术后7例患者分类为T3N0M0,2例为T3N1M0。1例T3N0M0患者术后不久因肺栓塞死亡。6例T3N0M0肿瘤患者中有2例存活超过5年,T3N1M0肿瘤患者均未存活超过3个月。晚期死亡原因包括胸壁癌复发(2例)、脑转移(1例)、心力衰竭(1例)及不明原因(2例)。在淋巴结未受累的情况下,胸壁侵犯对生存率无不利影响。文献报道平均手术死亡率为12%,中位生存时间约为1年,平均5年生存率为18%;手术切除对缓解疼痛也非常重要。